SANTAMARIA, ANGELO
 Distribuzione geografica
Continente #
EU - Europa 1.087
NA - Nord America 725
AS - Asia 172
OC - Oceania 5
SA - Sud America 3
AF - Africa 1
Totale 1.993
Nazione #
US - Stati Uniti d'America 723
IT - Italia 329
PL - Polonia 221
IE - Irlanda 208
SE - Svezia 180
CN - Cina 142
DE - Germania 28
FI - Finlandia 25
FR - Francia 23
UA - Ucraina 20
BE - Belgio 18
GB - Regno Unito 18
SG - Singapore 14
IN - India 12
NL - Olanda 7
AU - Australia 4
AT - Austria 3
EC - Ecuador 3
CA - Canada 2
CH - Svizzera 2
RO - Romania 2
RU - Federazione Russa 2
VN - Vietnam 2
AL - Albania 1
KR - Corea 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 1.993
Città #
Warsaw 220
Dublin 208
Chandler 141
Nyköping 100
Messina 85
Beijing 57
Ann Arbor 53
Jacksonville 53
Ashburn 41
Boardman 33
Cambridge 30
Dearborn 30
Princeton 29
Medford 26
Des Moines 22
Brussels 16
Catania 16
Jinan 16
Shenyang 13
Woodbridge 13
Wilmington 12
Tianjin 10
Rome 8
Seattle 8
Milan 7
Ningbo 7
Bremen 6
Pune 6
San Mateo 6
Washington 6
Bari 5
Hebei 5
Houston 5
Nanjing 5
Singapore 5
Cagliari 4
Haikou 4
New York 4
Scandicci 4
Taizhou 4
Trecastagni 4
Viagrande 4
Bologna 3
Capoterra 3
Hangzhou 3
Hefei 3
Hyderabad 3
Lanzhou 3
London 3
Mascalucia 3
Modling 3
Quito 3
Aci Sant'antonio 2
Acireale 2
Ascoli Piceno 2
Auburn Hills 2
Caltagirone 2
Dong Ket 2
Greifswald 2
Lancaster 2
Margherita di Savoia 2
Munich 2
Nanchang 2
Ottawa 2
Parma 2
Pomezia 2
Ravenna 2
Riva 2
Taiyuan 2
Verona 2
Vittoria 2
Waanrode 2
Zhengzhou 2
Akron 1
Anconetta 1
Argelato 1
Augusta 1
Baricella 1
Belgirate 1
Binasco 1
Brasov 1
Brescia 1
Brisbane 1
Brutten 1
Carini 1
Casalnuovo Di Napoli 1
Casette 1
Castrofilippo 1
Chennai 1
Corigliano Calabro 1
Crotone 1
Dolo 1
Dumfries 1
Dundee 1
Frontone 1
Fucecchio 1
Fuzhou 1
Garbagnate Milanese 1
Gurgaon 1
Helsinki 1
Totale 1.430
Nome #
Myo-Inositolo: protocollo non farmacologico per la prevenzione del Diabete Gestazionale - Outcomes clinici e metabolici 260
Inositolo e sindrome metabolica in menopausa 193
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 112
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 103
Italian risk factor-based screening for gestational diabetes. 94
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 85
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 77
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 75
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 75
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 74
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 71
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 71
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 70
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 68
Cadmium delays puberty onset and testis growth in adolescents 64
Myo-inositol and melatonin in the menopausal transition 63
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 60
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 59
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 53
Maternal serum PAPP-A as an early marker of obstetric complications? 49
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 47
Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension 46
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 45
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 44
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 42
Neutrophil Gelatinase-Associated Lipocalin (NGAL) e’ un marker di danno endoteliale? 35
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 26
Neutrophil Gelatinase-Associated Lipocalin (NGAL) e preeclampsia. 24
null 24
Totale 2.109
Categoria #
all - tutte 6.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020309 16 15 13 9 7 50 27 26 16 59 50 21
2020/2021334 20 14 65 13 29 16 33 37 44 44 12 7
2021/2022250 5 34 5 11 6 1 12 9 11 67 28 61
2022/2023597 43 78 27 32 46 52 7 24 261 1 23 3
2023/2024162 16 16 6 22 12 24 0 20 0 8 4 34
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 2.109